1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Evotec SE
  6. News
  7. Summary
    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

EVOTEC : Deutsche Bank sticks Neutral

12/01/2021 | 04:48am EDT

Deutsche Bank confirms his opinion on the stock and remains Neutral. The target price has been modified and is now set at EUR 39 compared to EUR 38.


© MarketScreener with dpa-AFX Analyser 2021
All news about EVOTEC SE
05/19Evotec Working With Almirall to Develop New Therapies for Skin Diseases
MT
05/19Evotec and Almirall enter into a multi-target alliance in medical dermatology
EQ
05/18Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell re..
AQ
05/18EVOTEC : Deutsche Bank maintains a Buy rating
MD
05/17TRANSCRIPT : Evotec SE, Sernova Corp. - M&A Call
CI
05/17Nasdaq-Listed Evotec and Sernova Detail Strategic Partnership For Therapy to Advance 'F..
MT
05/17Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based ..
AQ
05/17EVOTEC : RBC reaffirms its Buy rating
MD
05/17Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell re..
EQ
05/17Evotec SE and Sernova Corp Announces Partnership in the Field of Diabetes
CI
More news
Analyst Recommendations on EVOTEC SE
More recommendations
Financials
Sales 2022 682 M 722 M 722 M
Net income 2022 -4,70 M -4,98 M -4,98 M
Net cash 2022 88,2 M 93,4 M 93,4 M
P/E ratio 2022 -442x
Yield 2022 -
Capitalization 4 379 M 4 636 M 4 636 M
EV / Sales 2022 6,29x
EV / Sales 2023 5,33x
Nbr of Employees 4 354
Free-Float 87,7%
Chart EVOTEC SE
Duration : Period :
Evotec SE Technical Analysis Chart | EVT | DE0005664809 | MarketScreener
Technical analysis trends EVOTEC SE
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 24,78 €
Average target price 36,74 €
Spread / Average Target 48,3%
EPS Revisions
Managers and Directors
Werner Lanthaler Chief Executive Officer
Enno Spillner Chief Financial Officer
Iris Löw-Friedrich Chairman-Supervisory Board
Cord E. Dohrmann Chief Scientific Officer
Craig L. Johnstone Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
EVOTEC SE-41.69%4 636
MODERNA, INC.-43.55%54 775
LONZA GROUP AG-29.81%40 137
IQVIA HOLDINGS INC.-28.50%37 337
SEAGEN INC.-7.74%26 323
ICON PUBLIC LIMITED COMPANY-30.82%16 524